AMD Treatment Pipeline
Peer-reviewed articles on investigational therapies and a look at how they will affect your practice.
Will the AMD Therapies Now in Clinical Trials Deliver What They Promise?
By: Kay T. Adams
Two specialists discuss the possible impact on practice management and what we still need to know about the new drugs.
Intravitreal Injections: A Coding and Reimbursement Review
By: Kevin J. Corcoran, C.O.E., C.P.C., F.N.A.O.
The number of claims your practice files will increase as new therapeutic substances become available.
The Economics of Visudyne
The latest cost and reimbursement changes were a net positive, but attention to efficiency remains crucial.
By: Jason S. Slakter, M.D.
A New Forum for Retina Specialists
Insights from Industry
By: Flemming Orsnkov, M.D., M.P.H.; Cynthia Hogan
Diabetic Retinopathy: a Formidable Challenge
Assessing RPE Function with Autofluorescence